This is a scarce-asset compounder, not a moonshot. The upside comes from more AI,
HPC,
CSP and custom
ASIC demand flowing through the same bottlenecked node and packaging stack, plus better mix and commercial leverage, while valuation likely stays premium but does not need to explode higher. Size and
capex keep the outcome in the double, not tenfold, zone.